BioStem Technologies: Funding, Investors & Team (Oct 2026)
BioStem Technologies, Inc. is focused on promoting regenerative medicine and anti-aging methods in the USA, Europe, and Mexico. They are determined to provide premier wellness and stem cell products supported by research. Their aim is to be a leading force in the wellness industry by conducting scientific research and by producing top-quality nutraceuticals and stem cells. By possessing a cutting-edge laboratory, BioStem Technologies, Inc. takes a crucial initial step to display their commitment to enhancing well-being for the world and their investors.
BioStem Technologies has raised $2.7M across 2 funding rounds on record, the most recent an undisclosed round of $2.5M announced in May 2026.
That round is below the $8.1M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
BioStem Technologies Company Profile and Key Stats
Latest funding round on record: May 2026.
BioStem Technologies Funding Rounds
BioStem Technologies raised $220k in an undisclosed round announced in Apr 2023.
3.1 years later, an undisclosed round of $2.5M was announced in May 2026.
BioStem Technologies Founders and Leadership Team
Contact details for the BioStem Technologies team: 1 of 1 has an email address on file.
Start 14-day free trial →BioStem Technologies Funding Compared to Other Biotechnology Startups
BioStem Technologies' latest round of $2.5M is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like BioStem Technologies in Biotechnology and Pompano Beach
Companies Similar to BioStem Technologies
Kallyope, we believe that the gut is the gateway to our internal world. Containing millions of neurons, the…
Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain…
Tiny Health offers a gut health test specifically designed for mothers and babies aged 0 to 3 years.…
Junevity is dedicated to using cutting-edge transcription factor medicines to combat age-related diseases.…
Arkea Bio creates technology aimed at reducing greenhouse gas (GHG) emissions in the agricultural sector.
Serán is a contract development and manufacturing organization providing a comprehensive suite of…
Precision’s goal is to provide breakthrough treatments for the one billion patients worldwide suffering from…
Enveda is a biotechnology company that utilizes AI-powered tools to explore and characterize molecules from…
Avery Therapeutics, Inc. is a company dedicated to developing tissue engineered therapeutics to treat…
Circle Pharma is a biotechnology company in the initial stages of development that uses unique computational…
Evvy is for people with vaginas who want to be empowered with information about their microbiome. Their…
BioStem Technologies Funding FAQs
What does BioStem Technologies do?
BioStem Technologies, Inc. is focused on promoting regenerative medicine and anti-aging methods in the USA, Europe, and Mexico. They are determined to provide premier wellness and stem cell products supported by research. Their aim is to be a leading force in the wellness industry by conducting scientific research and by producing top-quality nutraceuticals and stem cells. By possessing a cutting-edge laboratory, BioStem Technologies, Inc. takes a crucial initial step to display their commitment to enhancing well-being for the world and their investors.
How much funding has BioStem Technologies raised?
BioStem Technologies has raised $2.7M across 2 rounds on record. The most recent is an undisclosed round of $2.5M announced in May 2026.
When did BioStem Technologies last raise funding?
BioStem Technologies' most recent funding round on record is an undisclosed round of $2.5M, announced in May 2026.
Who founded BioStem Technologies?
FundedIQ lists Jason Matuszewski (Founder) at BioStem Technologies.
Where is BioStem Technologies headquartered?
BioStem Technologies is based in Pompano Beach, Florida, United States.
How many employees does BioStem Technologies have?
BioStem Technologies is in the 11-50 employee band.
How does BioStem Technologies' funding compare to other Biotechnology startups?
BioStem Technologies' latest round of $2.5M is below the $8.1M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.
About FundedIQ's BioStem Technologies Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for BioStem Technologies is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.